A recently published study found that multiple injections of the gadolinium-based contrast agent (GBCA) gadodiamide resulted in gadolinium deposition in the brains of multiple sclerosis (MS) patients who were in the first five years of the disease. Patients who had received more than eight injections showed a tendency to have a higher number of … [Read more...]